Cargando…
Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types
Autores principales: | Ren, Shifang, Zhang, Zejian, Xu, Congjian, Guo, Lin, Lu, Renquan, Sun, Yihong, Guo, Jianming, Qin, Ruihuan, Qin, Wenjun, Gu, Jianxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973333/ https://www.ncbi.nlm.nih.gov/pubmed/27364686 http://dx.doi.org/10.1038/cr.2016.83 |
Ejemplares similares
-
Alteration of Serum IgG Galactosylation as a Potential Biomarker for Diagnosis of Neuroblastoma
por: Qin, Wenjun, et al.
Publicado: (2018) -
Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients
por: Zhong, Ailing, et al.
Publicado: (2019) -
Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling
por: Qin, Ruihuan, et al.
Publicado: (2020) -
Relative Quantitation of Subclass-Specific Murine
IgG Fc N-Glycoforms by Multiple Reaction Monitoring
por: Han, Jing, et al.
Publicado: (2020) -
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis
por: Liu, Jing, et al.
Publicado: (2019)